calendar
7,990 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
7,990 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
Items: 5.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 2.02, 5.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 8.01
Items: 1.01, 8.01, 9.01
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 2.01, 2.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01
Items: 3.01, 3.03, 5.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 8.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 8.01
Items: 5.02
Items: 5.02, 9.01
Items: 5.02, 5.03, 5.07, 9.01
Items: 2.01, 8.01, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 1.01, 3.03, 8.01, 9.01
Items: 2.02
Items: 5.07
Items: 7.01, 9.01
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Gastrointestinal, Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma), Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, Metastatic Liver Cancer
Therapy area: Central Nervous System. Indication: Unspecified Pain
Therapy area: Cardiovascular. Indication: Hypertension
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Undisclosed. Indication: Unspecified
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Central Nervous System, Dermatology, Ear Nose Throat Disorders, Gastrointestinal, Genito Urinary System, Infectious Disease, Mouth and Dental Disorders, Respiratory. Indication: Abscess, Acne Vulgaris, Acute Bacterial Sinusitis, Acute Bronchitis, Acute Pharyngitis, Bacterial Pneumonia, Bacterial Respiratory Tract Infections, Bartonella Infections, Bronchitis, Carbuncle, Cellulitis, Chlamydia trachomatis Pneumonia, Chronic Bronchitis, Community Acquired Pneumonia, Community-Acquired